Journal of Laboratory Medicine and Quality Assurance

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-7261   pISSN 2384-2458

Table. 19.

Table. 19.

2018 external quality assessment result of rapid antituberculous drug resistance test (RIF)

MTB DNA, drug (RIF) resistance mutation1st trial2nd trial3rd trial



GT1804GT1805GT1809GT1810GT1814GT1815






R (%)S (%)R (%)S (%)R (%)S (%)R (%)S (%)R (%)S (%)R (%)S (%)
Cepheid41 (100)41 (100)41 (100)41 (100)1 (2.4)40 (97.6)40 (97.6)1 (2.4)
 Xpert MTB/RIF41 (100)41 (100)41 (100)41 (100)1 (2.4)40 (97.6)40 (97.6)1 (2.4)
Hain Lifescience13 (100)13 (100)13 (100)13 (100)13 (100)13 (100)
 GenoType MTBDRplus13 (100)13 (100)13 (100)13 (100)13 (100)13 (100)
LG Chem7 (100)7 (100)7 (100)7 (100)7 (100)7 (100)
 AdvanSure TB/NTM real-time PCR7 (100)7 (100)7 (100)7 (100)7 (100)7 (100)
Others4 (100)4 (100)4 (100)4 (100)4 (100)4 (100)
Seegene3 (100)3 (100)3 (100)3 (100)3 (100)3 (100)
 Seegene anyplex MDR-TB detection3 (100)3 (100)3 (100)3 (100)3 (100)3 (100)
YD Diagnostics1 (100)1 (100)1 (100)1 (100)1 (100)1 (100)
 MolecuTech REBA MTB-MDR1 (100)1 (100)1 (100)1 (100)1 (100)1 (100)
All69 (100)69 (100)69 (100)69 (100)1 (1.5)69 (98.5)69 (98.5)1 (1.5)

The instrument used was from the following company: Cepheid (Sunnyvale, CA, USA); Hain Lifescience (Nehren, Germany); LG Chemical (Seoul, Korea); Seegene (Seoul, Korea); and YD Diagnostics (Yongin, Korea).

Abbreviations: MTB, Mycobacterium tuberculosis; R, resistant; S, susceptible; RIF, rifampicin; NTM, nontuberculous mycobacteria; PCR, polymerase chain reaction.

J Lab Med Qual Assur 2019;41:82-104 https://doi.org/10.15263/jlmqa.2019.41.2.82
© 2019 J Lab Med Qual Assur